SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-22-282054
Filing Date
2022-11-10
Accepted
2022-11-10 09:05:56
Documents
14
Period of Report
2022-11-10
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d408251d8k.htm   iXBRL 8-K 26258
2 EX-99.1 d408251dex991.htm EX-99.1 29241
6 GRAPHIC g408251g97c15.jpg GRAPHIC 9009
  Complete submission text file 0001193125-22-282054.txt   199918

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA vcnx-20221110.xsd EX-101.SCH 2861
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE vcnx-20221110_lab.xml EX-101.LAB 17980
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE vcnx-20221110_pre.xml EX-101.PRE 11262
8 EXTRACTED XBRL INSTANCE DOCUMENT d408251d8k_htm.xml XML 3390
Mailing Address 1895 MOUNT HOPE AVE ROCHESTER NY 14620
Business Address 1895 MOUNT HOPE AVE ROCHESTER NY 14620 585-271-2700
VACCINEX, INC. (Filer) CIK: 0001205922 (see all company filings)

IRS No.: 161603202 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38624 | Film No.: 221375238
SIC: 2834 Pharmaceutical Preparations